Yonsei University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 1,410 studies whose lead sponsor is Yonsei University. 235 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Yonsei University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Yonsei University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Stomach Neoplasms74Coronary Artery Disease68Atrial Fibrillation55Myocardial Ischemia27Breast Neoplasms26Stroke26Carcinoma, Non-Small-Cell Lung25Carcinoma22Colorectal Neoplasms22Lung Neoplasms21Acute Kidney Injury19Heart Failure19Diabetes Mellitus, Type 218Pancreatic Neoplasms17Carcinoma, Hepatocellular16Diabetes Mellitus16Ovarian Neoplasms16Vomiting16Emergence Delirium15Hepatitis15Hepatitis B, Chronic15Infarction15Acute Coronary Syndrome14Cardiomyopathies14
Show all 44 areas
Cardiovascular Diseases14Delirium14Dyslipidemias14Hypertension14Heart Valve Diseases13Liver Cirrhosis13Myocardial Infarction13Prostatic Neoplasms13Liver Diseases12Thyroid Neoplasms12Glaucoma11Ischemic Stroke11Postoperative Nausea and Vomiting11Adenocarcinoma10Adenoma10Carcinoma, Ovarian Epithelial10Cataract10Hypotension10Pain, Postoperative10Spinal Stenosis10
Studies
Recruiting first, then most recently updated. Showing 50 of 1,410. Browse all 1,410 →
- Subchondral Drilling Diameter During CARTISTEM Implantation for Knee Cartilage DefectsRecruitingNCT07881445Not applicable
- Clinical Cohort of Memory DisordersRecruitingNCT07880275
- Prospective Observational Study of Baseline Tumor Genomic Profiling and Circulating Tumor DNA in Neoadjuvant Chemoimmunotherapy for Stage IB-III Non-Small Cell Lung CancerRecruitingNCT06907160
- BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral AtherosclerosisRecruitingNCT07237308Phase 4
- Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical AtherosclerosisNot yet recruitingNCT07871604Phase 4
- Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCANot yet recruitingNCT07869602
- Gangwon PCI Prospective RegistryRecruitingNCT02038127
- An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer ChemotherapyNot yet recruitingNCT07845877Not applicable
- Lenvatinib in Patients With Advanced Parathyroid CarcinomaNot yet recruitingNCT07843901Phase 2
- Prospective Evaluation of AI Generated History of Present Illness Drafts in the Emergency DepartmentRecruitingNCT07804407
- Prognostic Value of Pulse Oximetry DifferencesRecruitingNCT07824414
- Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant MelanomaNot yet recruitingNCT07817901Phase 1/2
- Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's DiseaseNot yet recruitingNCT07804381Phase 2
- Coronary Access After Evolut FX Plus TAVI: Impact of Commissural Alignment and the Large-Cell Frame Design: ACCESS-FX+ RegistryNot yet recruitingNCT07813273
- Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung CancerNot yet recruitingNCT07640932Phase 2
- Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal CaptureNot yet recruitingNCT07804394Not applicable
- JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureNot yet recruitingNCT07798921Phase 1
- Sacituzumab Govitecan and Q901 in Advanced TNBCNot yet recruitingNCT07788222Phase 2
- Erector Spinae Oxygen Saturation and AKI After OPCABNot yet recruitingNCT07760129
- OptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial CarcinomaNot yet recruitingNCT07751796Not applicable
- Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant LeukemiaRecruitingNCT06516679Phase 2
- HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor ManagementNot yet recruitingNCT07721584Not applicable
- Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)RecruitingNCT07724171
- Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke PatientsRecruitingNCT07716475Not applicable
- A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOPNot yet recruitingNCT07702851Phase 2
- Perioperative Hypoglycemia in Diabetic Patients Undergoing Vitrectomy: a Masked CGM Prospective Observational StudyNot yet recruitingNCT07696910
- A Phase 2 Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07691476Phase 2
- Comparison of Operator Radiation Exposure During Percutaneous Coronary Intervention Between Left Distal and Right Conventional Radial AccessRecruitingNCT07579169Not applicable
- Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized TrialRecruitingNCT05705804Not applicable
- A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical GastrectomyNot yet recruitingNCT07687394Phase 4
- Aspirin vs Clopidogrel After TAVRRecruitingNCT05493657Not applicable
- Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVDRecruitingNCT07524101Not applicable
- The Purpose of This Clinical Trial is to Evaluate the Accuracy of Blood Pressure Measurement of HiCardi M350 Compared to Blood Pressure Measured by Auscultatory Sphygmomanometer in Adult Volunteers (Including Those Meeting Blood Pressure Distribution Requirements) in Accordance With ISO 81060-2:2018RecruitingNCT07622498Not applicable
- In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)Not yet recruitingNCT07622485Not applicable
- EVERolimus and LenvAtinib Versus Everolimus for Bone SarcomaNot yet recruitingNCT07619950Phase 2
- Ultra-hypofractionated Carbon-ion Therapy for Prostate CancerNot yet recruitingNCT07495293Phase 1
- Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart DiseaseRecruitingNCT07367893
- Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLCRecruitingNCT03694236Phase 1/2
- Clinical Effectiveness of a Motivational Interviewing-Based Conversational Mobile Application for High-Risk DrinkersRecruitingNCT07238998Not applicable
- Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter AblationRecruitingNCT06528262Phase 4
- sACB vs cACB in TKANot yet recruitingNCT07581886Not applicable
- A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)RecruitingNCT06023862Phase 2
- Simulation-Based Interprofessional Education for Operating Room TeamsNot yet recruitingNCT07570134Not applicable
- LBBAP vs. CS Pacing for CRT in Permanent Atrial Fibrillation and Heart Failure (SYNC-AF)Not yet recruitingNCT07560891Not applicable
- Registry Study on Rare Cancers in KoreaRecruitingNCT06746766
- Pemetrexed, Cisplatin With Soft Tissue SarcomaRecruitingNCT04605770Phase 2
- Comparison of Patient Understanding and Anxiety According to the Delivery Method of Educational VideosRecruitingNCT07550686Not applicable
- Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRventionRecruitingNCT07471867Phase 4
- Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue SarcomaNot yet recruitingNCT07547592Phase 2
- Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyNot yet recruitingNCT07544953Not applicable